Stocks · News reference
Santen Pharmaceutical Q1 EPS $0.11 Misses $0.12 Estimate, Sales $431.325M Beat $418.770M Estimate
Santen Pharmaceutical (OTC:SNPHY) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.12 by 8.33 percent. This is a 8.33 percent decrease over earnings of $0.12 per share
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 6, 2026, 11:37 AM
- Checked
- Aug 6, 2026, 11:37 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
No Linked Headlines Yet
The feed will populate when a captured headline is linked to this market.